Evidence map›Paper›PMID 22933067›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2012

Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus.

Denise A Kaminski, Chungwen Wei, Alexander F Rosenberg, F Eun-Hung Lee, Ignacio Sanz

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
9.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Rationale for B cell targeting in SLE.Seminars in immunopathology · 2014
    Review
  12. Advances in human B cell phenotypic profiling.Frontiers in immunology · 2012
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Denise A KaminskiDivision of Allergy, Immunology, and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Chungwen Wei
Alexander F Rosenberg
F Eun-Hung Lee
Ignacio Sanz
University of Rochester Medical Center · US

Funding

Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI WU, HULIN · 2010 to 2014
$10.8M
Translational Research Project Effector and Regulatory B cells in SLEU19AI056390 · NIAID · UNIVERSITY OF ROCHESTER · PI LOONEY, RICHARD JOHN · 2003 to 2013
$8.9M
A Model System for the Study of Human B-cell ToleranceR37AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2010 to 2019
$3.7M
Understanding the Generation of HIV Broadly Neutralizing AntibodiesR01AI084808 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2009 to 2013
$3.2M
A Model System for the Study of Human B-cell ToleranceR01AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2003 to 2007
$1.6M
NIAID NIH HHS AI56390NIAID NIH HHS P01 AI078907NIAID NIH HHS R01 AI049660NIAID NIH HHS R01 AI049660-01A1NIAID NIH HHS R01 AI084808NIAID NIH HHS R37 AI049660NIAID NIH HHS U19 AI056390
6 · The paper itself

Abstract

B lymphocyte involvement in systemic lupus erythematosus has been recognized for several decades, mainly in the context of autoantibody production. Both mouse and human studies reveal that different types of antibody responses, as well as antibody-independent effector functions can be ascribed to distinct subpopulations (subsets) of circulating B cells. Characterizing human B cell subsets can advance the field of autoimmunity even further by establishing B cell signatures associated with disease severity, progression, and response-to-treatment. For this purpose, we have developed specialized B cell reagent panels for multiparameter flow cytometry, and combine their use with advanced bioinformatics strategies that together will likely be advantageous for improving the characterization, prognosis, and for possibly improving treatment regimens of chronic inflammatory diseases such as lupus.

Indexed as

AnimalsBiological AssayB-LymphocytesCell SeparationFlow CytometryHumansImmunologic MemoryLupus Erythematosus, SystemicMicePhenotype

Identifiers

PMID22933067
PMCPMC3927893
OpenAlexW29463707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.